about
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Enga...
Read More
1.50
0.00
(0.00%)
14,794
XNAS Volume
XNAS 13 Mar, 2026 10:48 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Innate Pharma (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..